Reportlinker Adds Global Neurostimulation Industry
NEW YORK, Oct. 18 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Global Neurostimulation Industry
http://www.reportlinker.com/p098270/Global-Neurostimulation-Industry.html
This report analyzes the Global markets for Neurostimulation in US$ Million by the following Product Segments: Spinal Cord Stimulators (SCS) {Radio Frequency (RF) System, Implantable Pulse Generator (IPG)}, Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), and Vagus Nerve Stimulators (VNS). In addition to the above listed product segments, the report analyzes the US market for Neurostimulation by Gastric Electric Stimulators (GES). The report provides separate comprehensive analytics for the United States, and Rest of World. Annual estimates and forecasts are provided for each region for the period 2007 through 2015. Also, a seven-year historic analysis is provided for these markets .The report profiles 29 companies including many key and niche players such as Afferent Corp., Boston Scientific Corp., Cyberkinetics Neurotechnology Systems, Inc., Cyberonics, Inc., Medtronic, Inc., St. Jude Medical, Inc., and Synapse Biomedical, Inc. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.
NEUROSTIMULATION MCP-1227
A GLOBAL STRATEGIC BUSINESS REPORT
CONTENTS
1. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS 1
Study Reliability and Reporting Limitations 1
Disclaimers 2
Data Interpretation & Reporting Level 3
Quantitative Techniques & Analytics 3
Product Definitions and Scope of Study 3
Spinal Cord Stimulation (SCS) 4
Radio Frequency (RF) Systems 4
Implantable Pulse Generator Systems (IPGs) 4
Deep Brain Stimulation (DBS) 4
Sacral Nerve Stimulation (SNS) 4
Vagus Nerve Stimulation (VNS) 5
2. MARKET SNAPSHOTS 6
3. MARKET OVERVIEW 7
Rising Demand for Neurostimulation Devices 7
Current and Future Analysis 8
Table 1: Worldwide Neurostimulation Market (2007-2015):
Product Segments (Spinal Cord Stimulators, Deep Brain
Stimulators, Sacral Nerve Stimulators, and Vagus Nerve
Stimulators) Ranked by Growth (includes corresponding
Graph/Chart) 9
Neurostimulation Therapy Gets Popular 9
Technological Advancements So Far 10
SCS - The New Painkiller 10
Future Prospects 10
Obesity Control to Spur Market Growth in Future 11
4. TRENDS AND ISSUES 12
Chip Makers Struggle to Meet Quality Demand 12
Market Growth Attracts New Investors 12
Neurostimulation on a Rise with Growing Indications 12
Neurostimulation Market Marked by High Entry Barriers 12
Increasing Acceptance of Neurostimulation due to Advanced
Clinical Benefits 13
Powering Neurostimulation Devices-The Key to Success 13
Market Development Initiatives to Fuel Market Growth 14
Exploring Market Opportunities - The Technology Way 14
Neurostimulation Devices - Growing Awareness and Acceptance
Among Physicians 14
Synergy with Pharma & Biotech Companies Creates New Avenues 15
Third-Party Reimbursement - A Vital Role to Play 15
5. COMPETITIVE SCENARIO 16
Few Players Dominate Neurostimulation Market 16
Worldwide Neurostimulation Market: Leading Players by
Product Segment 16
Table 2: Leading Players in the Global Neurostimulation
Market (2009E): Percentage Share Breakdown of Value Sales
for Medtronic, St. Jude Medical, Boston Scientific,
Cyberonics and Others (includes corresponding Graph/Chart) 17
Table 3: World Neurostimulation Market (2009): Percentage
Share Breakdown of Value Sales for Pain, Deafness, Epilepsy,
Movement Disorders, Depression, Stroke, Incontinence,
Gastroparesis and Obesity (includes corresponding
Graph/Chart) 17
Product Offerings of Leading Players in the Neurostimulation
Market 18
Select Spinal Cord Stimulation Product Offerings of St. Jude
and Medtronic 18
Stimulation Parameters of Select SCS Products 19
Companies Researching Neurostimulator Applications by Indication 19
6. NEUROMODULATION INDUSTRY: AN INSIGHT 20
Attacking the Source of Pain - The Logic behind Neuromodulation 20
Growth Prospects for Neuromodulation Industry 20
7. PRODUCT OVERVIEW 22
Introduction to Neurostimulator 22
A Historical Note 22
Neurostimulation Devices by Product Segment 23
Spinal Cord Stimulation (SCS) 23
SCS - What it Treats 24
Segmentation by Type of Power Source 24
Implantable Pulse Generator Systems (IPGs) 24
Radio Frequency (RF) Systems 25
Market Assessment for RF Systems 25
Sacral Nerve Stimulation (SNS) 25
Deep Brain Stimulation (DBS) 26
Vagus Nerve Stimulation (VNS) 26
Gastric Electric Stimulation (GES) 27
Stimulation Device - How it Works 27
Neurostimulation & its Benefits 28
Prospective Application Areas for Neurostimulators - Select
Indications 28
Neurostimulation Indications and Use of Related Devices/
Techniques in the US 29
Approved Indications for Spinal Cord Stimulation by Geographic
Regions 29
Neurostimulation Devices - Technology & Safety Issues 30
8. RECENT INDUSTRY ACTIVITY 31
Sonova Holding Acquires Advanced Bionics 31
NeuroMetrix Purchases Select Assets of Cyberkinetics
Neurotechnology Systems 31
St. Jude Medical Purchases Non-Cash Assets and Intellectual
Property of Northstar Neuroscience 31
Victhom Human Bionics Signs Agreement with Otto Bock HealthCare 32
Neuros Medical Collaborates with Battelle 32
JumpStart & CTV Invest in Neuros Medical 32
InterWest Invests in Autonomic Technologies 33
MicroTransponder Finalizes Series A Funding Round for Wireless
Neurostimulator Development 33
NDI Medical Divests MEDSTIM Device to Medtronic 33
Cyberkinetics Neurotechnology Systems and NeuroMetrix Enters
into Joint Venture Agreement 34
Greatbatch Takes Over Quan Emerteq 34
RS Medical Takes Over CFS Medical 34
Cyberkinetics and Neurometrix Form Joint Venture to Develop
Andara™ OFS™ 35
St. Jude Bags CE Mark and FDA Approvals for Eon Mini™ 35
St. Jude Medical Initiates Clinical Study of DBS 35
ANS Bags CE Mark Approval for Rapid Programmer 3.0 36
Northstar Completes Trial of Renova-ST™ 36
Greatbatch Acquires Enpath Medical 36
Critical Therapeutics Grants Global License to Innovative
Metabolics 36
Biomet Merges with LVB Acquisition 37
US Patent and Trademark Office Issues Cyberkinetics' Patent
for Andara™OFS™ Therapy 37
Cyberonics Licenses Obesity-Related Patents 37
Stryker Invests in Afferent Corp 38
Medtronic Receives PMA Approval for Specify™ 5-6-5 Surgical Lead 38
BioControl Initiates CardioFit™ System's Trials 38
Medtronic Initiates Post-Market Study of InterStim™ 38
Cyberkinetics Successfully Tests Andara™OFS™ System 38
Medtronic Completes Implants in SANTE Trial of Deep Brain
Stimulation 38
Cyberonics Receives US FDA Approval for Demipulse™ and
Demipulse Duo™ 39
Cyberonics Signs Licensing Agreement with Ethicon Endo-Surgery 39
AMS Acquires Implantable Electrical Stimulation Platform
Technology from BioControl 39
Medtronic Bags FDA Approval on Interstim® 39
Boston's Precision SCS System Successfully Implanted 40
New Computer System to Improve Efficiency of Deep Brain
Stimulation 40
Cyberonics Bags FDA Approval for VNS Therapy System Labeling
Format 40
Impulse Dynamics Sponsors Study to Evaluate Optimizer 40
Medtronic to Pursue Major Clinical Trial of DBS 40
Cyberonics Bags FDA Real-Time Review Approval for Perennia™ Lead 40
Northstar Chooses AMI Semiconductor 41
American Medical Acquires Technology License from BioControl
Medical 41
American Medical Systems Holdings Takes Over the Urology Unit
of MedImpulse 41
Cyberkinetics Acquires Andara 42
Cyberkinetics Pacts with Minnetronix 42
Symphony Medical Strikes Deal with NDI Medical 42
NDI Opens New Business Unit 42
BRCP Funds Case to Extend Research Capabilities of ONNP 42
ANS Receives Clearance on Eon for European Market 42
Medtronic Receives FDA Nod for RestorePRIME 43
Boston Scientific Implants PRISM 43
Neuroscience Bags FDA Approval on P-Stim™ 43
Victhom Receives Patents from USPTO 43
9. PRODUCT INNOVATIONS/INTRODUCTIONS 44
Medtronic Unveils Brain Stimulation Products 44
Alphalife Launches Alpha Brainwave Neurostimulator 44
ImThera Medical Introduces aura6000™ Neurostimulation System 44
St. Jude Receives Approval for Neurostimulation System from
Japanese MHLW 44
St. Jude Secures European CE Mark Approval for Epiducer™ Lead
Delivery System 45
St. Jude Medical Obtains TGA Approval for Brio™ DBS System 45
Boston Scientific Secures FDA Approval for D4 and W4 SCS Lead
Splitters 45
Mobilis Healthcare Introduces InterX 46
IMEC Develops and Models New Design for Brain Stimulation
Implants 46
St. Jude Medical Receives Approval for Penta Neurostimulation
Lead from FDA 46
St. Jude Receives European CE Mark Approval for LibraXP™ and
Libra® Deep Brain Stimulation Systems 47
Medtronic Receives FDA Approval for Activa PC and Activa RC
DBS Devices 47
Medtronic Receives FDA Approval for Reclaim™ Deep Brain
Stimulation Therapy 47
St. Jude Receives European CE Mark Approval for Genesis®
Neurostimulation System 47
St. Jude Eon Mini™ Neurostimulator Receives Australian
Therapeutic Goods Administration Approval 48
Medtronic Receives FDA Approval for Activa® RC, Activa PC DBS
Devices 48
Medtronic Gains FDA Approval for RestoreULTRA™ Neurostimulator 49
St. Jude Receives European CE Mark and FDA Approval for EonC™ 49
St. Jude Receives Battery Longevity Approval from European CE
Mark and FDA for Eon® 49
Medtronic Delivers Procedural Intelligence in StealthStation®
System 50
Medtronic Unveils Patient Referral Advisor Software in US 50
Boston Scientific Introduces Smallest Rechargeable SCS System 50
Tennessee Inventors Develops Apparatus of Deep Brain Stimulator 51
California Inventors Develop IPG 51
Medtronic Rolls Out Two ImplanTable Neurostimulation Systems 51
Medtronic Introduces Two Latest Neurostimulation Systems 51
Neuroscience Therapy Launches P-Stim Electro Stimulation Device 52
NeuroPace and AMI Semiconductor Develops ImplanTableEpilepsy
Device 52
Neuroscience Launches P-Stim™ 52
AMI Semiconductor to Develop ASIC for New Stroke Therapy 53
Medtronic Unveils Two New Neurostimulation Systems 53
ANS Launches Rapid Programmer 3.0 53
10. FOCUS ON SELECT PLAYERS 54
Afferent Corp. (USA) 54
Boston Scientific Corp. (USA) 54
Cyberkinetics Neurotechnology Systems, Inc. (USA) 54
Cyberonics, Inc. (USA) 55
Medtronic, Inc. (USA) 55
St. Jude Medical, Inc. (USA) 56
Synapse Biomedical, Inc. (USA) 56
11. GLOBAL MARKET PERSPECTIVE 57
Table 4: World Recent Past, Current & Future Analysis for
Neurostimulation by Geographic Region - US and Rest of World
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for the Years 2007 through 2015 (includes
corresponding Graph/Chart) 57
Table 5: World Historic Review for Neurostimulation by
Geographic Region - US and Rest of World Markets Independently
Analyzed with Annual Sales Figures in US$ Million for the
Years 2000 through 2006 (includes corresponding Graph/Chart) 58
Table 6: World 11-Year Perspective for Neurostimulation by
Geographic Region - Percentage Breakdown of Value Sales for US
and Rest of World Markets for the Years 2005, 2010 and 2015 58
Table 7: World Recent Past, Current & Future Analysis for
Spinal Cord Stimulators by Geographic Region - US and Rest of
World Markets Independently Analyzed with Annual Sales Figures
in US$ Million for the Years 2007 through 2015 (includes
corresponding Graph/Chart) 59
Table 8: World Recent Past, Current & Future Analysis for
Spinal Cord Stimulators by Product Segment - Radio Frequency
(RF) System and Implantable Pulse Generator (IPG) Markets
Independently Analyzed with Annual Sales Figures in US$
Million for the Years 2007 through 2015 (includes
corresponding Graph/Chart) 59
Table 9: World Historic Review for Spinal Cord Stimulators by
Geographic Region - US and Rest of World Markets Independently
Analyzed with Annual Sales Figures in US$ Million for the
Years 2000 through 2006 (includes corresponding Graph/Chart) 60
Table 10: World Historic Review for Spinal Cord Stimulators by
Product Segment - Radio Frequency (RF) System and Implantable
Pulse Generator (IPG) Markets Independently Analyzed with
Annual Sales Figures in US$ Million for the Years 2000 through
2006 (includes corresponding Graph/Chart) 60
Table 11: World 11-Year Perspective for Spinal Cord
Stimulators by Geographic Region - Percentage Breakdown of
Value Sales for United States and Rest of the World Markets
for the Years 2005, 2010 and 2015 61
Table 12: World 11-Year Perspective for Spinal Cord
Stimulators by Product Segment - Percentage Breakdown of Value
Sales for Radio Frequency (RF) System and Implantable Pulse
Generator (IPG) Markets for the Years 2005, 2010 and 2015 61
Table 13: World Recent Past, Current & Future Analysis for
Radio Frequency Spinal Cord Stimulators by Geographic Region -
US and Rest of World Markets Independently Analyzed with
Annual Sales Figures in US$ Million for the Years 2007 through
2015 (includes corresponding Graph/Chart) 62
Table 14: World Historic Review for Radio Frequency Spinal
Cord Stimulators by Geographic Region - US and Rest of World
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for the Years 2000 through 2006 (includes
corresponding Graph/Chart) 62
Table 15: World 11-Year Perspective for Radio Frequency Spinal
Cord Stimulators by Geographic Region - Percentage Breakdown
of Value Sales for United States and Rest of the World Markets
for the Years 2005, 2010 and 2015 63
Table 16: World Recent Past, Current & Future Analysis for
Implantable Pulse Generator (IPG) Spinal Cord Stimulators by
Geographic Region - US and Rest of World Markets Independently
Analyzed with Annual Sales Figures in US$ Million for the
Years 2007 through 2015 (includes corresponding Graph/Chart) 64
Table 17: World Historic Review for Implantable Pulse
Generator (IPG) Spinal Cord Stimulators by Geographic Region -
US and Rest of World Markets Independently Analyzed with
Annual Sales Figures in US$ Million for the Years 2000 through
2006 (includes corresponding Graph/Chart) 64
Table 18: World 11-Year Perspective for Implantable Pulse
Generator (IPG) Spinal Cord Stimulators by Geographic Region -
Percentage Breakdown of Value Sales for US and Rest of World
Markets for the Years 2005, 2010 and 2015 65
Table 19: World Recent Past, Current & Future Analysis for
Deep Brain Stimulators by Geographic Region - US and Rest of
World Markets Independently Analyzed with Annual Sales Figures
in US$ Million for the Years 2007 through 2015 (includes
corresponding Graph/Chart) 66
Table 20: World Historic Review for Deep Brain Stimulators by
Geographic Region - US and Rest of World Markets Independently
Analyzed with Annual Sales Figures in US$ Million for the
Years 2000 through 2006 (includes corresponding Graph/Chart) 66
Table 21: World 11-Year Perspective for Deep Brain Stimulators
by Geographic Region - Percentage Breakdown of Value Sales for
United States and Rest of the World Markets for the Years
2005, 2010 and 2015 67
Table 22: World Recent Past, Current & Future Analysis for
Sacral Nerve Stimulators by Geographic Region - US and Rest of
World Markets Independently Analyzed with Annual Sales Figures
in US$ Million for the Years 2007 through 2015 (includes
corresponding Graph/Chart) 68
Table 23: World Historic Review for Sacral Nerve Stimulators
by Geographic Region - US and Rest of World Markets
Independently Analyzed with Annual Sales Figures in US$
Million for the Years 2000 through 2006 (includes
corresponding Graph/Chart) 68
Table 24: World 11-Year Perspective for Sacral Nerve
Stimulators by Geographic Region - Percentage Breakdown of
Value Sales for United States and Rest of the World Markets
for the Years 2005, 2010 and 2015 69
Table 25: World Recent Past, Current & Future Analysis for
Vagus Nerve Stimulators by Geographic Region - US and Rest of
World Markets Independently Analyzed with Annual Sales Figures
in US$ Million for the Years 2007 through 2015 (includes
corresponding Graph/Chart) 70
Table 26: World Historic Review for Vagus Nerve Stimulators by
Geographic Region - US and Rest of World Markets Independently
Analyzed with Annual Sales Figures in US$ Million for the
Years 2000 through 2006 (includes corresponding Graph/Chart) 70
Table 27: World 11-Year Perspective for Vagus Nerve
Stimulators by Geographic Region - Percentage Breakdown of
Value Sales for United States and Rest of the World Markets
for the Years 2005, 2010 and 2015 71
12. THE UNITED STATES 72
A. Market Analysis 72
Overview 72
Neurostimulation Products Market to Witness Growth 72
Product Segments Ranked by Growth 73
Table 28: Neurostimulation Market in the US (2007-2015):
Product Segments (Spinal Cord Stimulators (SCS), Deep
Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS),
Vagus Nerve Stimulators (VNS) and Gastric Electric
Stimulators (GES)) Ranked by Growth in Volume Sales
(includes corresponding Graph/Chart) 73
Table 29: Neurostimulation Market in the US (2007-2015):
Product Segments (SpinalCord Stimulators (SCS), Deep Brain
Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus
Nerve Stimulators (VNS) and Gastric Electric Stimulators
(GES)) Ranked by Growth in Value Sales (includes
corresponding Graph/Chart) 74
Table 30: Neurostimulation Market in the US (2010): Unit
Sales & Percentage Breakdown by Product Segment - Spinal
Cord Stimulators (SCS), Deep Brain Stimulators (DBS),
Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators
(VNS) and Gastric Electric Stimulators (GES) (includes
corresponding Graph/Chart) 74
Table 31: Neurostimulation Market in the US (2010): Value
Sales (in US$ Million) & Percentage Market Share by
Product Segment - Spinal Cord Stimulators (SCS), Deep
Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS),
Vagus Nerve Stimulators (VNS) and Gastric Electric
Stimulators (GES) (includes corresponding Graph/Chart) 75
Potential Growth for Neurostimulation Systems in the US 75
Spinal Cord Stimulation Products Market 75
Sacral Nerve Stimulation Products Market 76
Deep Brain Stimulation Products Market 77
Shift Away from Orthopaedic and Cardiovascular Device Markets 77
Trends in the Embolotherapy Market 78
Neurovascular Stents Market Attracting Cardiovascular Companies 78
Migraine Devices - New Frontiers for Neurostimulation 79
Competitive Landscape 79
Table 32: Leading Players in the US Neurostimulation Market
(2009E): Percentage Breakdown of Revenues for Medtronic,
Advanced Bionics, St. Jude Medical, Cyberonics and Others
(includes corresponding Graph/Chart) 80
B. Market Analytics 80
Table 33: US Recent Past, Current & Future Analysis for
Neurostimulators by Product Segment - Spinal Cord
Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral
Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and
Gastric Electric Stimulators (GES) Markets Independently
Analyzed with Annual Sales Figures in Units for Years 2007
through 2015 (includes corresponding Graph/Chart) 80
Table 34: US Recent Past, Current & Future Analysis for
Neurostimulators by Product Segment - Spinal Cord
Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral
Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and
Gastric Electric Stimulators (GES) Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2007 through 2015 (includes corresponding Graph/Chart) 81
Table 35: US Historic Review for Neurostimulators by Product
Segment - Spinal Cord Stimulators (SCS), Deep Brain
Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus
Nerve Stimulators (VNS), and Gastric Electric Stimulators
(GES) Markets Independently Analyzed with Annual Sales
Figures in Units for Years 2000 through 2006 (includes
corresponding Graph/Chart) 82
Table 36: US Historic Review for Neurostimulators by Product
Segment - Spinal Cord Stimulators (SCS), Deep Brain
Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus
Nerve Stimulators (VNS), and Gastric Electric Stimulators
(GES) Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2000 through 2006 (includes
corresponding Graph/Chart) 83
Table 37: US 11-Year Perspective for Neurostimulators by
Product Segment - Percentage Breakdown of Unit Sales for
Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS),
Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators
(VNS), and Gastric Electric Stimulators (GES) Markets for
the Years 2005, 2010 and 2015 (includes corresponding
Graph/Chart) 84
Table 38: US 11-Year Perspective for Neurostimulators by
Product Segment - Percentage Breakdown of Value Sales for
Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS),
Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators
(VNS), and Gastric Electric Stimulators (GES) Markets for
the Years 2005, 2010 and 2015 (includes corresponding
Graph/Chart) 85
Table 39: US Recent Past, Current & Future Analysis for
Spinal Cord Stimulators by Product Segment - Radio Frequency
(RF) System and Implantable Pulse Generator (IPG) Markets
Independently Analyzed with Annual Sales Figures in Units
for Years 2007 through 2015 (includes corresponding
Graph/Chart) 86
Table 40: US Recent Past, Current & Future Analysis for
Spinal Cord Stimulators by Product Segment - Radio Frequency
(RF) System and Implantable Pulse Generator (IPG) Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2007 through 2015 (includes corresponding
Graph/Chart) 86
Table 41: US Historic Review for Spinal Cord Stimulators by
Product Segment - Radio Frequency (RF) System and
Implantable Pulse Generator (IPG) Markets Independently
Analyzed with Annual Sales Figures in Units for Years 2000
through 2006 (includes corresponding Graph/Chart) 87
Table 42: US Historic Review for Spinal Cord Stimulators by
Product Segment - Radio Frequency (RF) System and
Implantable Pulse Generator (IPG) Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2000 through 2006 (includes corresponding Graph/Chart) 87
Table 43: US 11-Year Perspective for Spinal Cord Stimulators
by Product Segment - Percentage Breakdown of Unit Sales for
Radio Frequency (RF) System and Implantable Pulse Generator
(IPG) Markets for the Years 2005, 2010 and 2015 88
Table 44: US 11-Year Perspective for Spinal Cord Stimulators
by Product Segment - Percentage Breakdown of Value Sales for
Radio Frequency (RF) System and Implantable Pulse Generator
(IPG) Markets for the Years 2005, 2010 and 2015 88
13. REST OF WORLD 89
A. Market Analysis 89
Outlook 89
B. Market Analytics 89
Table 45: Rest of World Recent Past, Current & Future
Analysis for Neurostimulators by Product Segment - Spinal
Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral
Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and
Gastric Electric Stimulators (GES) Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2007 through 2015 (includes corresponding Graph/Chart) 89
Table 46: Rest of World Historic Review for Neurostimulators
by Product Segment - Spinal Cord Stimulators (SCS), Deep
Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS),
Vagus Nerve Stimulators (VNS), and Gastric Electric
Stimulators (GES) Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2000 through 2006
(includes corresponding Graph/Chart) 90
Table 47: Rest of World 11-Year Perspective for
Neurostimulators by Product Segment - Percentage Breakdown
of Value Sales for Spinal Cord Stimulators (SCS), Deep Brain
Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus
Nerve Stimulators (VNS), and Gastric Electric Stimulators
(GES) Markets for the Years 2005, 2010 and 2015 (includes
corresponding Graph/Chart) 91
Table 48: Rest of World Recent Past, Current & Future
Analysis for Spinal Cord Stimulators by Product Segment -
Radio Frequency (RF) System and Implantable Pulse Generator
(IPG) Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2007 through 2015 (includes
corresponding Graph/Chart) 92
Table 49: Rest of World Historic Review for Spinal Cord
Stimulators by Product Segment - Radio Frequency (RF) System
and Implantable Pulse Generator (IPG) Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2000 through 2006 (includes corresponding Graph/Chart) 93
Table 50: Rest of World 11-Year Perspective for Spinal Cord
Stimulators by Product Segment - Percentage Breakdown of
Value Sales for Radio Frequency (RF) System and Implantable
Pulse Generator (IPG) Markets for the Years 2005, 2010 and
2015 93
COMPETITIVE LANDSCAPE
Total Companies Profiled: 29 (including Divisions/Subsidiaries - 33)
------------------------------------------
Region/Country Players
------------------------------------------
The United States 25
Canada 1
Europe 6
The United Kingdom 2
Rest of Europe 4
Asia-Pacific (Excluding Japan) 1
------------------------------------------
To order this report:
Medical Devices Industry: Global Neurostimulation Industry
Check our Company Profile, SWOT and Revenue Analysis!
Contact Nicolas Bombourg |
|
Reportlinker |
|
Email: [email protected] |
|
US: (805)652-2626 |
|
Intl: +1 805-652-2626 |
|
SOURCE Reportlinker
Share this article